thefforest.co.uk

Stryker Sees Mako Softness in Q3

4.7 (653) · € 28.50 · En Stock

Stryker reported softer sales and installations of its Mako robot in the third quarter, but remains confident in the surgical robot overall.

Stryker's Mako Sales Were 'Super Impressive' in Q4 – OrthoFeed

Medical Device and Wound Care News and Analysis Blog

Stryker on LinkedIn: #wearestryker

Stryker reports third quarter 2023 operating results

Mako Stryker

a120447001_v3.jpg

Stryker: Mako Shoulder And Spine Launches Are On The Way (NYSE:SYK

a120447006_v3.jpg

Stryker Mako - Eminent Medical Center